Wu Nicholas C, Young Arthur P, Al-Mawsawi Laith Q, Olson C Anders, Feng Jun, Qi Hangfei, Luan Harding H, Li Xinmin, Wu Ting-Ting, Sun Ren
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA Molecular Biology Institute, University of California, Los Angeles, California, USA.
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
J Virol. 2014 Sep 1;88(17):10157-64. doi: 10.1128/JVI.01494-14. Epub 2014 Jun 25.
Viral proteins often display several functions which require multiple assays to dissect their genetic basis. Here, we describe a systematic approach to screen for loss-of-function mutations that confer a fitness disadvantage under a specified growth condition. Our methodology was achieved by genetically monitoring a mutant library under two growth conditions, with and without interferon, by deep sequencing. We employed a molecular tagging technique to distinguish true mutations from sequencing error. This approach enabled us to identify mutations that were negatively selected against, in addition to those that were positively selected for. Using this technique, we identified loss-of-function mutations in the influenza A virus NS segment that were sensitive to type I interferon in a high-throughput fashion. Mechanistic characterization further showed that a single substitution, D92Y, resulted in the inability of NS to inhibit RIG-I ubiquitination. The approach described in this study can be applied under any specified condition for any virus that can be genetically manipulated.
Traditional genetics focuses on a single genotype-phenotype relationship, whereas high-throughput genetics permits phenotypic characterization of numerous mutants in parallel. High-throughput genetics often involves monitoring of a mutant library with deep sequencing. However, deep sequencing suffers from a high error rate (∼0.1 to 1%), which is usually higher than the occurrence frequency for individual point mutations within a mutant library. Therefore, only mutations that confer a fitness advantage can be identified with confidence due to an enrichment in the occurrence frequency. In contrast, it is impossible to identify deleterious mutations using most next-generation sequencing techniques. In this study, we have applied a molecular tagging technique to distinguish true mutations from sequencing errors. It enabled us to identify mutations that underwent negative selection, in addition to mutations that experienced positive selection. This study provides a proof of concept by screening for loss-of-function mutations on the influenza A virus NS segment that are involved in its anti-interferon activity.
病毒蛋白通常具有多种功能,需要通过多种测定来剖析其遗传基础。在此,我们描述了一种系统方法,用于筛选在特定生长条件下导致适应性劣势的功能丧失突变。我们的方法是通过深度测序在有和没有干扰素的两种生长条件下对突变文库进行遗传监测来实现的。我们采用了一种分子标记技术来区分真实突变和测序错误。这种方法使我们能够识别出除了那些被正向选择的突变之外,还被负向选择的突变。使用这种技术,我们以高通量方式鉴定了甲型流感病毒NS片段中对I型干扰素敏感的功能丧失突变。机制表征进一步表明,单个取代D92Y导致NS无法抑制RIG-I泛素化。本研究中描述的方法可应用于任何可进行基因操作的病毒在任何特定条件下。
传统遗传学侧重于单一的基因型-表型关系,而高通量遗传学允许并行表征众多突变体的表型。高通量遗传学通常涉及通过深度测序监测突变文库。然而,深度测序存在较高的错误率(约0.1%至1%),这通常高于突变文库中单个点突变的发生频率。因此,由于发生频率的富集,只有那些赋予适应性优势的突变才能被可靠地鉴定出来。相比之下,使用大多数下一代测序技术无法鉴定有害突变。在本研究中,我们应用了一种分子标记技术来区分真实突变和测序错误。这使我们能够识别出经历负向选择的突变以及经历正向选择的突变。本研究通过筛选参与甲型流感病毒NS片段抗干扰素活性的功能丧失突变提供了概念验证。